Navigation Links
Non-whites receive harsher sentences for inflicted traumatic brain injury of children
Date:6/4/2008

eal with this problem.

"In most of these cases the perpetrators are not acting with the intent of hurting the baby. Instead they are usually frustrated young parents who respond to a crying baby with 30 seconds of stupidity, because they weren't educated about the dangers of shaking a baby," Runyan said. "In my view, harsh prison sentences may not be the most appropriate response in this situation, and we need to seriously consider other ways of dealing with what is a significant public health problem."

The study's lead author is Heather T. Keenan, Ph.D., who was a graduate student at UNC and now is an associate professor at the University of Utah. Maryalice Nocera, a research nurse with the UNC Injury Prevention Research Center, is a co-author.

"It is difficult to know what the appropriate judicial response should be to these cases as the value of the child's lost life or abilities need to be recognized," Keenan said. "However, it is clear that the response should not be based on the defendants' race or ethnicity."

This study follows up on an earlier study by the same researchers, which was published in the Journal of the American Medical Association in 2003. Their goal this time was to find out how the justice system treats suspected perpetrators of one specific form of child physical maltreatment, inflicted traumatic brain injury.

They found 75 substantiated cases of inflicted traumatic brain injury among children ranging from infants to 2-year-olds. Of these, criminal charges were filed in 54 cases. Forty-one of the defendants pleaded either guilty or no contest to the charges and 10 defendants went to jury trial. Three were found not guilty, leaving 48 defendants with criminal convictions. Of these, 30 (63 percent) were sentenced to time in prison.

Whether or not the child died was found to have an effect on the severity of charges that were filed; defendants faced more serious charges when the child died. H
'/>"/>

Contact: Patric Lane
patric_lane@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy
2. Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
3. China Sky One Medical, Inc. Receives SFDA Approval for Five Patches
4. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
5. VIDEO from Medialink and Abiomed: Worlds Smallest Heart Pump Receives 510(K) Clearance from FDA
6. AMSA PharmFree Scorecard Grades U.S. Medical Schools on Conflict-of-Interest Policies; Only 7 Receive an A
7. Bradmer receives FDA approval to proceed with Phase III clinical trial
8. Orlando: June 13-16; National Convention on Mental Illness; Jane Pauley to Receive Award
9. Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
10. ATK Receives Laureate Award From Computerworld Honors Program for Storage and Data Protection Innovation Featuring Overlands Products
11. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Vancouver personal injury lawyers at Jiwa ... now handle personal injury claims resulting due to bus ... more and more people turn towards mass transportation for ... suffering, serious injury and also deaths. , “If ... accident in BC you may have an ICBC Claim,” ...
(Date:6/3/2015)... 03, 2015 VeoMed and Decker ... online and mobile access to premier Continuing Medical ... of Certification (MOC) activities. , ... courses to Decker’s extensive lists of physicians, residents, ... access to VeoMed’s premier online and live-streamed courses. ...
(Date:6/3/2015)... Plano, Texas (PRWEB) June 03, 2015 ... Intelligence and Analytics solutions, today announced the launch ... Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio. ... embed additional visualization capabilities and advanced functionalities into ... of the DSX suite, Visual BI is adding ...
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 According ... Inquisitr police officers intercepted fake oxycodone pills which ... pills were doctored to look legitimate, and even sported ... officers are warning those consuming 30 mg oxycodone to ... the pills online or buy them illegally on the ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional ... digital-first business are rewriting the rules for business as ... for traditional businesses to take on a more agile ... services. On top of this there is a ... to bring new innovation and approaches to business. , ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... more predominant in women, the reasons for this are ... on the risk and severity of RA, but the ... data from the Womens Health Initiative (WHI) clinical trials ... significant differences in the risk of developing RA or ...
... in Australian Research During an Event ... 2 April, PHILADELPHIA and LONDON, Feb. 28 ... ; TSX: TOC) and leading provider,of information solutions to ... honor Australia,s preeminent,researchers at the National Press Club in ...
... TAMPA, Fla., Feb. 27 Sirion Therapeutics, ... that its New Drug Application (NDA) for ... and Drug Administration (FDA) and granted,priority review. ... FDA for,its investigational compound Durezol(TM) (difluprednate ophthalmic,emulsion) ...
... Screening breast cancers for three receptors could help doctors ... A study published in the open access journal Breast ... negative for estrogen receptor (ER), progesterone receptor (PR) and ... appear to be most at risk from developing brain ...
... Revenues Up 38.8%, Nine-Month Revenues Up 40.6%, ETHEX Revenue ... Months Ther-Rx Revenue Up ... ST. LOUIS, Feb. 27 KV Pharmaceutical Company,(NYSE: ... and first nine months of fiscal 2008 ended December ...
... CORAL SPRINGS, Fla., Feb. 27 Boca Pharmacal, ... Administration has granted,final approval for the Company,s Abbreviated ... of Pamlab,s Palgic(R) Oral Solution,(Carbinoxamine Maleate Oral Solution) ... immediately., Carbinoxamine Maleate Oral Solution 4mg/5mL is ...
Cached Medicine News:Health News:Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 2Health News:Thomson Scientific To Honor Australia's Top Researchers With Dedicated Australian Research Day 3Health News:Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation 2Health News:Breast cancer subtypes linked to survival from secondary brain tumors 2Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 2Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 3Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 4Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 5Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 6Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 7Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 8Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 9Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 10Health News:KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis 11
(Date:6/3/2015)... AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ... today that their customer, Pharmabox, has introduced the world,s ... carries over 140 top selling brand name items typically ... Rite Aid-type store. As published in ... Miami -based Pharmabox worked with AVT to develop ...
(Date:6/3/2015)... , June 3, 2015  Flow cytometry ... around the globe and keeping track of wide-ranging ... competitive market. In particular, ensuring user-friendliness, fluorescence capabilities, ... are the most important factors influencing end-user purchase ... base. New analysis from Frost & ...
(Date:6/3/2015)... June 3, 2015 Varian Medical Systems (NYSE: ... selected to equip and service the new multi-room HollandPTC ... The company will book the equipment part of the ... HollandPTC is a key part of Medical Delta, the ... of Leiden, Delft and Rotterdam . ...
Breaking Medicine Technology:Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4Varian Medical Systems to Equip Proton Therapy Center in Netherlands 2Varian Medical Systems to Equip Proton Therapy Center in Netherlands 3
... Diagnostics Incorporated (NYSE: DGX ), the world,s leading ... Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended ... shares of common stock of Celera Corporation (NASDAQ: ... p.m., New York City time, today, May 3, 2011, unless ...
... Calif., May 3, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... that it has entered into a definitive agreement with ... Life Sciences, to raise approximately $16.1 million in gross ... of common stock and warrants.  The Company agreed to ...
Cached Medicine Technology:Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 2Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 3Alexza Prices $16.1 Million Registered Direct Offering 2Alexza Prices $16.1 Million Registered Direct Offering 3Alexza Prices $16.1 Million Registered Direct Offering 4
Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium....
Medicine Products: